Aster DM Healthcare’s Board approved the unaudited financial results for the quarter and half-year ended September 30, 2025. Non-Executive Director, Anoop Moopen, resigned effective November 6, 2025, due to other commitments. Further, TJ Wilson was appointed to the Nomination and Remuneration Committee. The board also identified new registered office premises in Hyderabad, pending regulatory approval. An agenda item on the Employee Stock Option Scheme was deferred.
Financial Results Approved
Aster DM Healthcare’s Board of Directors approved the unaudited standalone financial results for Q2 2026 (Jul-Sep). Key figures from the standalone results include:
- Revenue from operations: INR 681.81 crores
- Total Income: INR 726.45 crores
- Profit after tax: INR 104.61 crores
The board also reviewed the limited review report issued by the Statutory Auditor, Deloitte Haskins & Sells, which had an unmodified opinion on the financial results.
Director Resignation and Committee Changes
Anoop Moopen resigned from his position as Non-Executive Director of the Company, effective close of business hours on November 6, 2025, due to other commitments. Consequently, he also ceased to be a member of various Board Committees.
TJ Wilson was inducted as a member of the Nomination and Remuneration Committee, effective November 6, 2025.
New Registered Office in Hyderabad
The Board identified new registered office premises in Hyderabad, Telangana, subject to regulatory approval for shifting the registered office from Karnataka. The proposed address is:
No. 7-1-450/20, Plot No. 04, Mythri Vihar, Ameerpet, Hyderabad, Telangana – 500038.
Employee Stock Option Scheme Update
The consideration and approval of the proposed Employee Stock Option Scheme 2025 were deferred to a subsequent meeting for further review and clarification.
Source: BSE
